Back to Search
SANJAY JAGANNATH, M.D.
M.D.
Gastroenterology Physician
NPI: 1730136870IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gastroenterology PhysicianPrimary
Internal Medicine — Gastroenterology
Code: 207RG0100X
2015-02088(NC)
Education
UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE
Class of 1995
Research & Publications (20)
New drugs in multiple myeloma and the significance of autologous stem cell transplants.
PMID 19398940·Clin Adv Hematol Oncol·2009
8-other
Extended follow-up of a phase 2 trial of bortezomib alone and in combination with dexamethasone for the frontline treatment of multiple myeloma.
PMID 19622094·Br J Haematol·2009
3-trial
Treatment of patients with myeloma with comorbid conditions: considerations for the clinician.
PMID 18952546·Clin Lymphoma Myeloma·2008
6-review
Updated survival analyses after prolonged follow-up of the phase 2, multicenter CREST study of bortezomib in relapsed or refractory multiple myeloma.
PMID 18783399·Br J Haematol·2008
3-trial
Pathophysiological underpinnings of multiple myeloma progression.
PMID 18774880·J Manag Care Pharm·2008
8-other
Current standards for first-line therapy of multiple myeloma.
PMID 17877846·Clin Lymphoma Myeloma·2007
6-review
Bortezomib appears to overcome the poor prognosis conferred by chromosome 13 deletion in phase 2 and 3 trials.
PMID 17096017·Leukemia·2007
4-observational
Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology.
PMID 18021469·Clin Lymphoma Myeloma·2007
8-other
Bortezomib in combination with dexamethasone for the treatment of patients with relapsed and/or refractory multiple myeloma with less than optimal response to bortezomib alone.
PMID 16818280·Haematologica·2006
4-observational
The safety and efficacy of bortezomib in relapsed multiple myeloma.
PMID 16830423·Clin Adv Hematol Oncol·2006
8-other
Treatment of myeloma in patients not eligible for transplantation.
PMID 15869735·Curr Treat Options Oncol·2005
6-review
Bortezomib in recurrent and/or refractory multiple myeloma. Initial clinical experience in patients with impared renal function.
PMID 15690325·Cancer·2005
4-observational
Bortezomib therapy alone and in combination with dexamethasone for previously untreated symptomatic multiple myeloma.
PMID 15953004·Br J Haematol·2005
3-trial
A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma.
PMID 15461622·Br J Haematol·2004
3-trial
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
PMID 19020545·Leukemia·2009
6-review
Disparities in demographics among patients with pancreatitis-related mortality.
PMID 19287112·JOP·2009
8-other
Awareness of guidelines and trends in the management of suspected pancreatic cystic neoplasms: survey results among general gastroenterologists and EUS specialists.
PMID 18926529·Gastrointest Endosc·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2601 LAKE DR, STE 201
RALEIGH, NC 27607 - Phone
- (919) 783-4888
Quick Facts
- NPI
- 1730136870
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile